LOS ANGELES, Sept. 29, 2022 (GLOBE NEWSWIRE) — Irwin Naturals Inc. I WIN IWINF (FRA: 97X) (“Irwin” or the “Company”) today announced a definitive agreement to purchase all of the issued and outstanding shares of Keta Media, LLC dba Ketamine Media (“Ketamine Media”), the nation’s leading growth platform for clinics offering ketamine-assisted therapies. With a global network dedicated to improving patient outcomes, KM has established relationships with clinics in over 45 states and three countries, connecting providers and patients with a unique patient-centric communications approach.
Klee Irwin, CEO of Irwin, said, “While this transaction will directly contribute to our profitability, strategic considerations are primarily driving this acquisition. Ketamine Media will support our mission to bring healing to people living with mental illness. We are in acquisition discussions with many clinics who tell us that Ketamine Media has been largely responsible for their growth and we are excited to have them as part of the Irwin family.”
Irwin anticipates that the acquisition will help expedite the identification and completion of new potential clinic transactions and will be able to leverage KM’s capabilities to increase utilization rates at its existing and future branded clinics to increase emergence. KM’s approach to education and awareness aligns seamlessly with Irwin’s mission to bring a truly disruptive therapy to the masses with significantly higher cure rates compared to traditional therapies.
Chris Walden, CEO of Ketamine Media added, “We will continue to provide the high level of service that our customers have come to expect. For us, this transaction gives us access to growth capital that will enable Ketamine Media to add new consulting services that will enable all of our clients to benefit greatly at a much faster pace. Ketamine Media wants to help encourage more collaboration in this burgeoning space between vendors in local markets….
